| Literature DB >> 35886381 |
Sarah J D Nauwelaerts1,2, Koen De Cremer3, Natalia Bustos Sierra4, Mathieu Gand1, Dirk Van Geel1, Maud Delvoye1, Els Vandermassen1, Jordy Vercauteren5, Christophe Stroobants5, Alfred Bernard2, Nelly D Saenen6, Tim S Nawrot6,7, Nancy H C Roosens1, Sigrid C J De Keersmaecker1.
Abstract
Air pollution exposure can lead to exacerbation of respiratory disorders in children. Using sensitive biomarkers helps to assess the impact of air pollution on children's respiratory health and combining protein, genetic and epigenetic biomarkers gives insights on their interrelatedness. Most studies do not contain such an integrated approach and investigate these biomarkers individually in blood, although its collection in children is challenging. Our study aimed at assessing the feasibility of conducting future integrated larger-scale studies evaluating respiratory health risks of air pollution episodes in children, based on a qualitative analysis of the technical and logistic aspects of a small-scale field study involving 42 children. This included the preparation, collection and storage of non-invasive samples (urine, saliva), the measurement of general and respiratory health parameters and the measurement of specific biomarkers (genetic, protein, epigenetic) of respiratory health and air pollution exposure. Bottlenecks were identified and modifications were proposed to expand this integrated study to a higher number of children, time points and locations. This would allow for non-invasive assessment of the impact of air pollution exposure on the respiratory health of children in future larger-scale studies, which is critical for the development of policies or measures at the population level.Entities:
Keywords: air pollution; biomarkers; children; epidemiological studies; feasibility; non-invasive; ozone; particulate matter
Mesh:
Substances:
Year: 2022 PMID: 35886381 PMCID: PMC9323067 DOI: 10.3390/ijerph19148531
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Flowchart of the feasibility study, comprising the several steps of design, preparation, the orchestration of the field study and the analysis of the measured parameters, including the time frame required for each of these steps. AP: air pollution; β2M: beta-2-microglobulin; BM: biomarker; BP: blood pressure; CC16: club cell protein; CLB: pupil guidance center, DIC: document of informed consent; FeNO: fractional exhaled nitric oxide; LF: lung function; RT: room temperature; SNP: single nucleotide polymorphism; TET-1: ten-eleven translocation methylcytosine dioxygenase 1; UGRP1: uteroglobin-related protein.
Overview of field study participation rate and information retrieved from questionnaire and follow-up letter.
| Urban | Rural | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Participation a |
| % | N |
| % | N |
| % | N |
| Children participating | 19 | 53 | 36 | 23 | 41 | 56 | 42 | 46 | 92 |
| No response/no interest | 17 | 47 | 36 | 33 | 59 | 56 | 50 | 54 | 92 |
| Parents accept but child does not want to participate | 3 | 18 | 17 | 1 | 0 | 33 | 4 | 8 | 50 |
| Child accepts but parents do not want child to participate | 2 | 12 | 17 | 0 | 0 | 33 | 2 | 4 | 50 |
| Both parent and child do not want to participate | 12 | 71 | 17 | 32 | 97 | 33 | 44 | 88 | 50 |
|
| |||||||||
| Completed questionnaires (partially or fully completed) | 19 | 100 | 19 | 23 | 100 | 23 | 42 | 100 | 42 |
| Type of questions answered incompletely 1 | |||||||||
| Frequency or age of a certain condition in childhood | 4 | 53 | 7 3 | 5 | 68 | 7 3 | 9 | 60 | 14 3 |
| Frequency of a certain activity performed by the child | 3 | 43 | 9 3 | 4 | 59 | 9 3 | 7 | 39 | 18 3 |
| Questions related to smoking habits of the mother or father | 8 | 53 | 13 3 | 1 | 33 | 3 3 | 9 | 56 | 16 3 |
| Incomplete probably due to recto–verso layout | 2 | 11 | 19 | 0 | 0 | 23 | 2 | 5 | 42 |
|
| |||||||||
|
| |||||||||
| Completed by parents of all children (participating and non-participating) | 10 | 28 | 36 | 44 | 79 | 56 | 54 | 59 | 92 |
| Consent received from child | 9 | 90 | 10 | 21 | 48 | 44 | 30 | 56 | 54 |
| Consent received from parents | 9 | 90 | 10 | 23 | 52 | 44 | 32 | 59 | 54 |
| Completed by parents of participating children | 9 | 47 | 19 | 21 | 91 | 23 | 30 | 71 | 42 |
| Completed by parents of non-participating children | 1 | 6 | 17 | 23 | 70 | 33 | 24 | 48 | 50 |
|
| |||||||||
| Reason for no consent/no participation from the child | |||||||||
| No answer (not filled in) | 0 | 0 | 1 | 5 | 22 | 23 | 5 | 21 | 24 |
| Scared | 0 | 0 | 1 | 6 | 26 | 23 | 6 | 25 | 24 |
| No interest | 0 | 0 | 1 | 8 | 35 | 23 | 8 | 33 | 24 |
| Other reasons 2 | 1 | 100 | 1 | 4 | 17 | 23 | 5 | 21 | 24 |
| Reason for no consent for child to participate from the parent | |||||||||
| No answer (not filled in) | 0 | 0 | 1 | 7 | 33 | 21 | 7 | 32 | 22 |
| Scared | 0 | 0 | 1 | 1 | 5 | 21 | 1 | 5 | 22 |
| No interest | 0 | 0 | 1 | 4 | 19 | 21 | 4 | 18 | 22 |
| Only one of the parents consented | 0 | 0 | 1 | 1 | 5 | 21 | 1 | 5 | 22 |
| Other reasons 2 | 1 | 100 | 1 | 8 | 38 | 21 | 9 | 41 | 22 |
|
| |||||||||
| No answer (not filled in) | 0 | 0 | 9 | 1 | 5 | 21 | 1 | 3 | 30 |
| Enthusiastic | 3 | 33 | 9 | 12 | 57 | 21 | 15 | 50 | 30 |
| Uncomfortable | 0 | 0 | 9 | 0 | 0 | 21 | 0 | 0 | 30 |
| No opinion | 4 | 44 | 9 | 8 | 38 | 21 | 12 | 40 | 30 |
| Other/not specified | 2 | 22 | 9 | 0 | 0 | 21 | 2 | 7 | 30 |
|
| |||||||||
| From the children participating in the current study | |||||||||
| Parent not willing to let child participate again | 1 | 11 | 9 | 1 | 5 | 21 | 2 | 7 | 30 |
| Parents willing give consent again for a new study | 8 | 89 | 9 | 20 | 95 | 21 | 28 | 93 | 30 |
| Number of times/year that new study can be conducted | |||||||||
| No answer (not filled in) | 1 | 13 | 8 | 3 | 15 | 20 | 4 | 14 | 28 |
| 2×/year | 3 | 38 | 8 | 9 | 45 | 20 | 12 | 43 | 28 |
| 3×/year | 1 | 13 | 8 | 3 | 15 | 20 | 4 | 14 | 28 |
| 4×/year | 2 | 25 | 8 | 3 | 15 | 20 | 5 | 18 | 28 |
| As much as needed | 1 | 13 | 8 | 2 | 10 | 20 | 3 | 11 | 28 |
| Consent for sampling | 7 | 88 | 8 | 20 | 100 | 20 | 27 | 96 | 28 |
| Consent for sample type—not specified (not filled in) | 1 | 14 | 7 | 1 | 5 | 20 | 2 | 7 | 27 |
| Consent for sample of urine | 6 | 86 | 7 | 19 | 100 | 19 | 25 | 96 | 26 |
| Consent for sample of saliva | 6 | 86 | 7 | 18 | 95 | 19 | 24 | 92 | 26 |
| Consent for sample of NALF | 5 | 71 | 7 | 9 | 47 | 19 | 14 | 54 | 26 |
| Consent for sample of feces | 3 | 43 | 7 | 10 | 53 | 19 | 13 | 50 | 26 |
| Consent for sample of blood | 3 | 43 | 7 | 9 | 47 | 19 | 12 | 46 | 26 |
| Consent for sample of blood if parents receive: | |||||||||
| blood type information for their child | 0 | 0 | 7 | 13 | 68 | 19 | 13 | 50 | 26 |
| personal results from the study for their child | 0 | 0 | 7 | 12 | 63 | 19 | 12 | 46 | 26 |
| From the children not participating in the current study | |||||||||
| Parent not willing to let child participate again | 0 | 0 | 1 | 13 | 57 | 23 | 13 | 54 | 24 |
| Parents did not answer (not filled in) | 0 | 0 | 1 | 8 | 35 | 23 | 8 | 33 | 24 |
| Parents willing to give consent again for a new study | 1 | 100 | 1 | 2 | 9 | 23 | 3 | 13 | 24 |
| Number of times/year that new study can be conducted | |||||||||
| no answer (not filled in) | 1 | 100 | 1 | 2 | 100 | 2 | 3 | 100 | 3 |
N: total number of subjects evaluated for specific statement/category mentioned in first column; n: number of subjects that complied with statement/category mentioned in first column; a data obtained from DIC and assent for parents and child, respectively; 1: determined as the number of questionnaires where more than 20% of the parents did not answer a specific question. Average of all the questions related to the same topic. 2: other reasons—other activities after school, reticent to give urine sample, medical reason, document not returned in time, child not yet enrolled at that school at the start of the study; 3: this N does not correspond to the total number of questionnaires/subjects but refers to the number of questionnaires in which parents answered a main question but did not always give a complete answer to the additional related questions. The number of questionnaires where this type of additional question remained unanswered is represented by n.
Air pollutants, measured at the two time points of the field study.
| Urban | Rural | |||
|---|---|---|---|---|
| Measuring Station | t1 | t2 | t1 | t2 |
| Ozone | 68 | 34 | 80 | 50 |
| BC | 0.7 | NA | 0.9 | 2.3 |
| NO2 | 41 | 49 | 29 | 62 |
| PM10 | 13 | 29 | 17 | 24 |
| PM2.5 | 5 | 19 | 9 | 13 |
|
| ||||
| Streetside | 1.9 | 5.3 | / | / |
|
| ||||
| Streetside | 7.1 | 34.8 | 22.3 | 8.9 * |
| Playground | 4 | 30.4 | 26.2 | 8.9 * |
| Classroom | 5.2 | 12.7 | 14.6 | 3.9 * |
All pollutants are expressed in µg/m³. For the measuring station, levels from day of the study (lag 0) are shown—Ozone: daily highest 8-h mean ozone concentrations (00h00 till 24h00); PM2.5, PM10 and BC: daily mean concentrations (00h00 till 24h00). * unexpected low values, potentially due to an Airbeam issue. NO2: daily highest mean NO2 concentrations (00h00 till 24h00). The pollutant levels measured by the stationary measuring station up to two days (lag 2, lag 1) before the examinations are not shown in the table. For the portable instruments (portable BC monitor and Airbeam), mean concentration of values was measured during the time lapse of the study. PM10 and PM1 levels measured by the Airbeam are not shown. BC: black carbon; PM10: particulate matter with a diameter smaller than 10 μm; PM2.5: particulate matter with a diameter smaller than 2.5 μm; NA: not available; /: not measured; t1: time point 1 (summer); t2: time point 2 (winter).